A detailed history of Envestnet Asset Management Inc transactions in Merus N.V. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 13,984 shares of MRUS stock, worth $784,082. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,984
Holding current value
$784,082
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 29, 2025

BUY
$39.01 - $49.16 $545,515 - $687,453
13,984 New
13,984 $588,000
Q3 2024

Nov 06, 2024

BUY
$47.19 - $58.84 $244,821 - $305,261
5,188 New
5,188 $259,000

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.57B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.